Wharton's jelly-mesenchymal stem cells treatment for severe COVID 19 patients: 1-year follow-up
{{output}}
Background: Recently, attention has been focused on mesenchymal stem cells (MSC) because of their unique ability to suppress inflammation induced by cytokine storms caused by COVID-19. Several patients have been successfully trea... ...
